Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
551
DELISTED
Radius Recycling
RDUS
| $1.18M | ﹤0.01% |
+36,066
| New | +$1.54M |
|
552
State Street SPDR S&P Capital Markets ETF
KCE
$472M
| $1.18M | ﹤0.01% |
16,200
+2,539
| +19% | +$203K |
|
553
CF Industries
CF
$18B
| $1.16M | ﹤0.01% |
13,572
-129,688
| -91% | -$12.6M |
|
|
RYZ
554
Ryerson Holding Corp
RYZ
$1.44B
| $1.16M | ﹤0.01% |
+54,339
| New | +$1.7M |
|
555
Collegium Pharmaceutical
COLL
$1.17B
| $1.16M | ﹤0.01% |
65,219
+14,800
| +29% | +$249K |
|
556
Lockheed Martin
LMT
$134B
| $1.15M | ﹤0.01% |
2,672
+222
| +9% | +$97.5K |
|
557
iShares TIPS Bond ETF
TIP
$14.5B
| $1.15M | ﹤0.01% |
10,066
+2,662
| +36% | +$316K |
|
558
Ford
F
$56.8B
| $1.15M | ﹤0.01% |
102,850
+9,829
| +11% | +$135K |
|
559
Accenture
ACN
$103B
| $1.14M | ﹤0.01% |
4,118
+2,230
| +118% | +$670K |
|
560
Credicorp
BAP
$31.8B
| $1.14M | ﹤0.01% |
9,465
+1,402
| +17% | +$193K |
|
561
Lexicon Pharmaceuticals
LXRX
$1.09B
| $1.13M | ﹤0.01% |
605,528
+237,334
| +64% | +$453K |
|
562
iShares MSCI ACWI ETF
ACWI
$33.4B
| $1.09M | ﹤0.01% |
12,987
+83
| +0.6% | +$7.55K |
|
|
JNPR
563
DELISTED
Juniper Networks
JNPR
| $1.09M | ﹤0.01% |
38,139
+1,163
| +3% | +$36.7K |
|
564
Arista Networks
ANET
$249B
| $1.07M | ﹤0.01% |
45,496
+1,060
| +2% | +$29.1K |
|
565
Pricesmart
PSMT
$5.98B
| $1.06M | ﹤0.01% |
14,833
+6,915
| +87% | +$536K |
|
|
EGRX
566
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.06M | ﹤0.01% |
23,864
+9,800
| +70% | +$450K |
|
567
Vanguard Industrials ETF
VIS
$8.45B
| $1.05M | ﹤0.01% |
6,409
+994
| +18% | +$176K |
|
568
Vanguard Information Technology ETF
VGT
$148B
| $1.05M | ﹤0.01% |
25,624
-2,272
| -8% | -$102K |
|
|
HOLX
569
DELISTED
Hologic
HOLX
| $1.02M | ﹤0.01% |
14,663
+213
| +1% | +$15.8K |
|
570
PNC Financial Services
PNC
$102B
| $998K | ﹤0.01% |
6,323
-898
| -12% | -$151K |
|
|
CLDT
571
Chatham Lodging
CLDT
$624M
| $995K | ﹤0.01% |
95,169
+17,079
| +22% | +$215K |
|
572
Philip Morris
PM
$292B
| $969K | ﹤0.01% |
9,810
-454
| -4% | -$46.3K |
|
573
iShares MSCI Switzerland ETF
EWL
$2.22B
| $968K | ﹤0.01% |
23,301
-2,876
| -11% | -$129K |
|
574
Affiliated Managers Group
AMG
$10.1B
| $946K | ﹤0.01% |
8,111
+2,405
| +42% | +$310K |
|
575
iShares California Muni Bond ETF
CMF
$4.6B
| $918K | ﹤0.01% |
16,254
+776
| +5% | +$43.8K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.